BMY
BRISTOL MYERS SQUIBB CO
Key Financials
Net Income
$7.1B
↑ 178.8%
Operating Income
$1.4B
N/A
Gross Profit
$30.7B
↑ 276.9%
EPS (Diluted)
$3.46
↑ 178.5%
Total Assets
$90.0B
↓ 2.8%
Shareholders' Equity
$18.5B
↑ 13.1%
Revenue
$48.2B
↓ 0.2%
Cash & Equivalents
$10.2B
↓ 1.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BMY |
| Company Name | BRISTOL MYERS SQUIBB CO |
| CIK | 14272 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6092524621 |